These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9681752)

  • 1. Spontaneous rupture of polyurethane peritoneal catheter. A possible deleterious effect of mupirocin ointment.
    Riu S; Ruiz CG; Martinez-Vea A; Peralta C; Oliver JA
    Nephrol Dial Transplant; 1998 Jul; 13(7):1870-1. PubMed ID: 9681752
    [No Abstract]   [Full Text] [Related]  

  • 2. A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin.
    Bernardini J; Piraino B; Holley J; Johnston JR; Lutes R
    Am J Kidney Dis; 1996 May; 27(5):695-700. PubMed ID: 8629630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site.
    Thodis E; Bhaskaran S; Pasadakis P; Bargman JM; Vas SI; Oreopoulos DG
    Perit Dial Int; 1998; 18(3):261-70. PubMed ID: 9663889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Management of PD catheter complication].
    Kubota M
    Nihon Rinsho; 2004 May; 62 Suppl 5():303-6. PubMed ID: 15197934
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of peritoneal dialysis catheter infections in Saudi peritoneal dialysis patients: the emergence of high-level mupirocin resistance.
    Al-Hwiesh AK; Abdul-Rahman IS; Al-Muhanna FA; Al-Sulaiman MH; Al-Jondebi MS; Divino-Filho JC
    Int J Artif Organs; 2013 Jul; 36(7):473-83. PubMed ID: 23897229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylaxis against gram-positive organisms causing exit-site infection and peritonitis in continuous ambulatory peritoneal dialysis patients by applying mupirocin ointment at the catheter exit site.
    Wong SS; Chu KH; Cheuk A; Tsang WK; Fung SK; Chan HW; Tong MK
    Perit Dial Int; 2003 Dec; 23 Suppl 2():S153-8. PubMed ID: 17986538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous peritoneal catheter extrusion.
    Nowicki M; Jander A; Czupryniak A; Kaluzynska A
    Perit Dial Int; 2002; 22(2):277-8. PubMed ID: 11990420
    [No Abstract]   [Full Text] [Related]  

  • 8. Resistance to mupirocin: no indication of it to date while using mupirocin ointment for prevention of Staphylococcus aureus exit-site infections in peritoneal dialysis patients.
    Vas SI; Conly J; Bargman JM; Oreopoulos DG
    Perit Dial Int; 1999; 19(4):313-4. PubMed ID: 10507810
    [No Abstract]   [Full Text] [Related]  

  • 9. Is it possible to decrease the rate of Staphylococcus aureus peritonitis?
    Piraino B
    Perit Dial Int; 1996; 16(5):446-7. PubMed ID: 8914174
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of weekly mupirocin application on infections in continuous ambulatory peritoneal dialysis patients.
    Zeybel M; Ozder A; Sanlidag C; Yildiz S; Cavdar C; Ersoy R; Celik A; Camsari T
    Adv Perit Dial; 2003; 19():198-201. PubMed ID: 14763062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Pulse" nasal mupirocin maintenance regimen in patients undergoing continuous ambulatory peritoneal dialysis.
    Mylotte JM; Kahler L; Jackson E
    Infect Control Hosp Epidemiol; 1999 Nov; 20(11):741-5. PubMed ID: 10580624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mupirocin once weekly reduces the incidence of catheter exit-site infection in peritoneal dialysis patients.
    Al-Hilali NA; Ninan VT; Al-Humoud HA; Nampoory MR; Johny KV
    Perit Dial Int; 2005; 25(1):91-2. PubMed ID: 15770932
    [No Abstract]   [Full Text] [Related]  

  • 13. The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis.
    Thodis E; Passadakis P; Panagoutsos S; Bacharaki D; Euthimiadou A; Vargemezis V
    Adv Perit Dial; 2000; 16():257-61. PubMed ID: 11045306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of topical mupirocin on peritoneal dialysis infection rates in Singapore General Hospital.
    Lim CT; Wong KS; Foo MW
    Nephrol Dial Transplant; 2005 Aug; 20(8):1702-6. PubMed ID: 15855200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of catheter-related infections.
    Piraino B
    Am J Kidney Dis; 1996 May; 27(5):754-8. PubMed ID: 8629641
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of once- or thrice-weekly mupirocin application on mupirocin resistance in patients on continuous ambulatory peritoneal dialysis--first 6 months' experience.
    Cavdar C; Zeybel M; Atay T; Sifil A; Sanlidag C; Gulay Z; Camsari T
    Adv Perit Dial; 2004; 20():62-6. PubMed ID: 15384797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open study of mupirocin in Libyan patients with skin infections.
    El Ferghani N
    J Int Med Res; 1995; 23(6):508-17. PubMed ID: 8746621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous Fracture in Intramural and Intra-Abdominal Segments of Peritoneal Dialysis Catheters Presenting as Outflow Failure.
    Wadhawan A; Saxena R
    Perit Dial Int; 2019; 39(3):289-291. PubMed ID: 31088934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smaller insertion angle of Tenckhoff catheter increases the chance of catheter migration in CAPD patients.
    Hwang SJ; Chang JM; Chen HC; Tsai MK; Tsai JC; Hsu CH; Hsiao PW; Tsai CY; Guh JY; Lai YH
    Perit Dial Int; 1998; 18(4):433-5. PubMed ID: 10505568
    [No Abstract]   [Full Text] [Related]  

  • 20. Structural changes in silicon rubber peritoneal dialysis catheters in patients using mupirocin at the exit site.
    Khandelwal M; Bailey S; Izatt S; Chu M; Vas S; Bargman J; Oreopoulos D
    Int J Artif Organs; 2003 Oct; 26(10):913-7. PubMed ID: 14636007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.